Sales decline 5.27% to Rs 1395.10 crore
Net Loss of Ranbaxy Laboratories reported to Rs 608.81 crore in the quarter ended June 2013 as against net loss of Rs 925.67 crore during the previous quarter ended June 2012. Sales declined 5.27% to Rs 1395.10 crore in the quarter ended June 2013 as against Rs 1472.75 crore during the previous quarter ended June 2012. ParticularsQuarter EndedJun. 2013Jun. 2012% Var.Sales1395.101472.75 -5 OPM %-10.81-11.93 -PBDT-275.86-277.79 1 PBT-320.51-326.32 2 NP-608.81-925.67 34Powered by Capital Market - Live News


